TY - JOUR KW - Adolescent KW - Aged KW - *Brain Ischemia/complications KW - *Cardiovascular Diseases/complications KW - Cholesterol, LDL KW - Humans KW - Male KW - *Myocardial Infarction/drug therapy KW - Retrospective Studies KW - Risk Factors KW - *Stroke/complications/epidemiology KW - United Kingdom/epidemiology KW - Cardiology KW - Coronary heart disease KW - GENERAL MEDICINE (see Internal Medicine) KW - Quality in health care AU - M. Danese AU - E. Sidelnikov AU - G. Villa AU - D. Catterick AU - M. Iqbal AU - M. Gleeson AU - D. Lubeck AU - J. Patel AD - Outcomes Insights Inc, Agoura Hills, California, USA mark@outins.com. Health Economics and Outcomes Research, Amgen Europe GmbH, Rotkreuz, Switzerland. Value & Access, Amgen Limited, Uxbridge, UK. Outcomes Insights Inc, Agoura Hills, California, USA. Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK. AN - 35487737 BT - BMJ Open DO - 10.1136/bmjopen-2021-055015 DP - NLM ET - 2022/04/30 LA - eng M1 - 4 N1 - 2044-6055 Danese, Mark Orcid: 0000-0002-7068-9603 Sidelnikov, Eduard Villa, Guillermo Catterick, David Iqbal, Mazhar Gleeson, Michelle Lubeck, Deborah Patel, Jeetesh Journal Article England BMJ Open. 2022 Apr 29;12(4):e055015. doi: 10.1136/bmjopen-2021-055015. PY - 2022 SN - 2044-6055 EP - e055015 T2 - BMJ Open TI - Longitudinal evaluation of treatment patterns, risk factors and outcomes in patients with cardiovascular disease treated with lipid-lowering therapy in the UK VL - 12 ER -